Total Number of Communication Reports: 1
Monthly communication reports in the last 6 months: 0
Commercialization of therapeutic immunomodulatory viral proteins to combat inflammatory diseases. We interact with TPC and receive benefits as per awarded project #7720-492480. TPC falls within the jurisdiction of the Industry Minister.
Kevin Sullivan, Director of Business Development
End date of the last completed financial year: 2008-03-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Technology Partnerships Canada | $1,660,000.00 | Yes |
Address:
700 Collip Circle, Suite 203
London, ON N6G 4X8
Canada
Telephone number:
519-858-5109
Fax number:
519-858-5120
Viron Therapeutics Inc. is not a subsidiary of any other parent companies.
Viron Therapeutics Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking